ArticlePharmacoEconomics2025

Heterogeneity in Economic Value of SGLT2is for Type 2 Diabetes: Subgroup Modeling Cost-Effectiveness Analyses.

Kah Suan Chong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.